Related Experiment Video

Updated: Mar 14, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.7K

Treatment outcomes in pediatric melanoma-Are there benefits to specialized care?

Benjamin Freemyer1, Emma Hamilton1, Carla L Warneke2

  • 1Department of Pediatric Surgery, The McGovern Medical School at the University of Texas Health Science Center at Houston, 6431 Fannin Street, Suite 5.258, Houston, TX 77030.

Journal of Pediatric Surgery
|October 1, 2016
PubMed

Insights

Pediatric melanoma patients treated at specialized cancer centers show improved survival rates. Comprehensive care, particularly for advanced stages, significantly enhances outcomes for young melanoma patients.

Area of Science:

  • Oncology
  • Pediatric Medicine
  • Cancer Research

Background:

  • Pediatric melanoma is a rare but serious diagnosis.
  • Outcomes for pediatric melanoma can vary based on treatment setting.
  • National Cancer Institute (NCI)-designated centers offer specialized cancer care.

Purpose of the Study:

  • To investigate the effect of hospital specialization on survival in pediatric melanoma patients.
  • To compare outcomes between patients treated at an NCI-designated center versus non-NCI centers.

Main Methods:

  • Retrospective review of pediatric cutaneous melanoma patients (under 18) treated from 2000-2014.
  • Comparison of overall survival (OS) and disease-free survival (DFS) between two groups: Group A (all treatment at MDACC) and Group B (initial surgery at non-NCI center).
  • Kaplan-Meier analysis and log-rank testing were used for survival comparisons. Study level: III.

Main Results:

  • Patients treated entirely at MDACC (Group A) demonstrated significantly better OS and DFS compared to Group B (p<0.001).
  • Five-year OS was 97% for Group A versus 88% for Group B.
  • Survival benefits were most pronounced in Stage 3 and 4 pediatric melanoma patients, with Group A showing higher 5-year OS (91.2% vs 80.8%) and DFS (94.4% vs 77.2%).

Conclusions:

  • Treatment at a comprehensive cancer center may lead to improved survival for pediatric melanoma.
  • Specialized care is particularly beneficial for pediatric melanoma patients with advanced-stage disease (Stage III/IV).
  • Hospital specialization is a critical factor in optimizing outcomes for young patients with melanoma.
Abstract

Keywords:
OutcomesPediatric melanomaSpecializationSurvival

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.2K
A Melanoma Patient-Derived Xenograft Model07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.3K

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K